Code
|
8386C
|
MA number
|
19/0212/18-S
|
Product Form:
|
tbl slg 49x1x2 mg/0,5 mg (blis.OPA/Al/PVC/Al - jednodáv.bal.)
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
Type of procedure:
|
Decentralised
|
MAH, country:
|
G.L. Pharma GmbH, Austria
|
Therapeutic Class:
|
19 - ANTIDOTA, DETOXICANTIA
|
ATC:
|
N |
NERVOUS SYSTEM |
N07 |
OTHER NERVOUS SYSTEM DRUGS |
N07B |
DRUGS USED IN ADDICTIVE DISORDERS |
N07BC |
Drugs used in opioid dependence |
N07BC51 |
Buprenorphine, combinations |
|
Shelf life:
|
36 |
Container:
|
blister OPA/Al/PVC/Al
|
Route of admin.:
|
Sublingual use
|